NCT05210712View on ClinicalTrials.gov

Respiratory Rate Validation Study - RS001.2 Respiree Cardio-Respiratory Monitor

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

February 10, 2022

Study Completion Date

February 10, 2022

Conditions
A Minimum of 30 Adults, Ages 18 Years and Older
Interventions
DEVICE

RS001.2 Respiree Cardio-Respiratory Monitor

The RS001.2 Respiree Cardio-Respiratory Monitor is intended as a noninvasive multiparameter monitor on the adult population

Trial Locations (1)

80027

Clinimark, Louisville

All Listed Sponsors
lead

Respiree Pte Ltd

INDUSTRY